Report Categories
View AllRecent Articles
View All
JM Smucker SJM Faces Lower Forward Estimates After JPMorgan Price Target Cut
Samsungs Bonus Deal Puts Pressure on Corporate South Koreas Wage Structures
Morning Market Roundup Microns Milestone Dicks Earnings and Paxtons Primary Victory
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
Cruz and Cantwells Potential College Football Legislation Raises Industry Concerns
BCC Q1 2026 Earnings EPS Surges Past Estimates with 1826 Surprise
ISTR Q1 2026 Earnings Strong EPS Beat Driven by Improved Margins and Loan Growth
Beazer Homes BZH Q1 2026 Earnings Surprise EPS Beat Defies Expectations
XTNT Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain
NABL Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Gains Despite Miss
Nuveen New York Municipal Value Fund NNY Edges Higher Amid Steady Muni Demand
James Hardie Industries JHX Rises 267 Testing Key Resistance as Volume Picks Up
Lantheus Holdings Slips 188 as Shares Approach Key Support Zone
Barnwell Industries BRN Holds Steady at 108 as Consolidation Continues
Berenberg Chief Economist Warns ECB Rate Hikes a Big Mistake Amid Stagflation Risks
Alberta Separatism Vote Potential Implications for Canadas Energy Sector and Investment Climate
Apple Incs Growth Narrative Gains Momentum Amid Expanding Services and Ecosystem Strength
Japans Nikkei 225 Breaches 65000 for First Time as Oil Prices Slide on Hormuz Reopening Hopes
External Links
UK Exports to US Slump 25 Following Trumps Liberation Day Tariff Actions
ACAD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds
DTE Energy Q1 2026 Earnings EPS Misses Estimates by 387 Despite Positive Stock Response
JOUT Q1 2026 Earnings Earnings Beat Amidst Challenging Outdoor Market Conditions
NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged
PLMR Q1 2026 Earnings Palomar Holdings Beats EPS Estimates by 301
SENEA Q1 2026 Earnings Strong EPS of 619 Amid Quiet Market Reaction
Stratasys SSYS Q1 2026 Earnings NarrowerThanExpected Loss Sparks Positive Reaction
NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43
CPSS Q4 2025 Earnings Mixed Results as EPS Falls Short of Estimates